How many drugs treat Sedation in Intubated Patients?

Drug Landscape tracks 4 marketed treatments for Sedation in Intubated Patients (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/sedation-in-intubated-patients.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Sedation in Intubated Patients — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sedation in Intubated Patients (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Sedation in Intubated Patients, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Diprivan	Propofol	Fresenius Kabi	General anesthetic	GABA A receptors	1989-01-01
Versed	midazolam	Generic (originally Roche)	Benzodiazepine (short-acting)	Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2	1985-12-20
Versed	Midazolam Hydrochloride	Takeda Pharmaceutical Company Limited	Benzodiazepine	GABA A receptor alpha-5/beta-2/gamma-2	1985-01-01
Diprivan	Diprivan	St. Antonius Hospital		Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Fresenius Kabi · 1 drug in Sedation in Intubated Patients
Generic (originally Roche) · 1 drug in Sedation in Intubated Patients
St. Antonius Hospital · 1 drug in Sedation in Intubated Patients
Takeda Pharmaceutical Company Limited · 1 drug in Sedation in Intubated Patients

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Sedation in Intubated Patients:

Cite this brief

Drug Landscape (2026). Sedation in Intubated Patients — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/sedation-in-intubated-patients. Accessed 2026-06-11.

Sedation in Intubated Patients full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing